How harmless turns dangerous
Causes for bloodstream infections found in the genes of bacteria: This will enable better diagnostics and vaccinations in the future
The bacteria have caused increasingly more diseases
Prof. Dr. Marco Galardini's Team team has studied this in more detail and found that E. coli has a significant genetic variation that contributes to the transition between the harmless life in the intestine (commensalism) and the pathogenic form. In addition, the researchers were also able to show that this bacterial species has evolved more toward causing disease over the years. "Building on these findings, we envision the creation of better molecular diagnostic tools in the future, and these results might also be important for vaccines development," says Prof. Galardini. The team published their findings in the journal PLoSGenetics. First authors are Judit Burgaya and Julie Marin. The work originated in TWINCORE in collaboration with Prof. Erick Denamur (INSERM, Paris) and Prof. François Blanquart (Collège de France). Marco Galardini holds a professorship funded by the RESIST Cluster of Excellence at the Hannover Medical School (MHH), he leads the research group "Systems Biology of Microbial Communities" at the Institute of Molecular Bacteriology of TWINCORE.
Significant genetic differences between harmless and dangerous bacteria
The team examined a collection of about 900 E. coli isolates that caused blood infections and 370 harmless isolates. The samples were collected over a 17-year period (from 2000 to 2017) by the team of Prof. Erick Denamur. "We found significant differences between the disease-causing and the harmless isolates – both in their pangenomes, i.e. the totality of genes of the respective isolates, and in their genetic backgrounds, in terms of the presence of virulence-associated genes and antimicrobial resistance genes," says Prof. Galardini. Using another commensal collection from 1980, the group also found that pathogenicity might have increased steadily from 1980 through 2000 to 2010.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.